These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17632702)

  • 1. Continuous stimulation of human glucagon-like peptide-1 (7-36) amide in a mouse model (NOD) delays onset of autoimmune type 1 diabetes.
    Zhang J; Tokui Y; Yamagata K; Kozawa J; Sayama K; Iwahashi H; Okita K; Miuchi M; Konya H; Hamaguchi T; Namba M; Shimomura I; Miyagawa JI
    Diabetologia; 2007 Sep; 50(9):1900-1909. PubMed ID: 17632702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy with glucagon-like peptide-1 and gastrin restores normoglycemia in diabetic NOD mice.
    Suarez-Pinzon WL; Power RF; Yan Y; Wasserfall C; Atkinson M; Rabinovitch A
    Diabetes; 2008 Dec; 57(12):3281-8. PubMed ID: 18835930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice.
    Wang Q; Brubaker PL
    Diabetologia; 2002 Sep; 45(9):1263-73. PubMed ID: 12242459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucagon-like-peptide-1 (7-36) amide improves glucose sensitivity in beta-cells of NOD mice.
    Linn T; Schneider K; Göke B; Federlin K
    Acta Diabetol; 1996 Mar; 33(1):19-24. PubMed ID: 8777280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of new-onset diabetes through modulating inflammation and stimulating beta-cell replication in nonobese diabetic mice by a dipeptidyl peptidase IV inhibitor.
    Tian L; Gao J; Hao J; Zhang Y; Yi H; O'Brien TD; Sorenson R; Luo J; Guo Z
    Endocrinology; 2010 Jul; 151(7):3049-60. PubMed ID: 20444936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioactive GLP-1 in gut, receptor expression in pancreas, and insulin response to GLP-1 in diabetes-prone rats.
    Valverde I; Wang GS; Burghardt K; Kauri LM; Redondo A; Acitores A; Villanueva-Peñacarrillo ML; Courtois P; Sener A; Cancelas J; Malaisse WJ; Scott FW
    Endocrine; 2004 Feb; 23(1):77-84. PubMed ID: 15034199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated glucagon-like peptide-1 plasma levels, as a possible adaptive response, in diabetic NOD mice.
    Rydgren T; Börjesson A; Carlsson A; Sandler S
    Biochem Biophys Res Commun; 2012 Jul; 423(3):583-7. PubMed ID: 22695119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Islet remodeling in female mice with spontaneous autoimmune and streptozotocin-induced diabetes.
    Plesner A; Ten Holder JT; Verchere CB
    PLoS One; 2014; 9(8):e102843. PubMed ID: 25101835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GLP-1(28-36) improves β-cell mass and glucose disposal in streptozotocin-induced diabetic mice and activates cAMP/PKA/β-catenin signaling in β-cells in vitro.
    Shao W; Wang Z; Ip W; Chiang YT; Xiong X; Chai T; Xu C; Wang Q; Jin T
    Am J Physiol Endocrinol Metab; 2013 Jun; 304(12):E1263-72. PubMed ID: 23571712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon-like peptide-1 induces cell proliferation and pancreatic-duodenum homeobox-1 expression and increases endocrine cell mass in the pancreas of old, glucose-intolerant rats.
    Perfetti R; Zhou J; Doyle ME; Egan JM
    Endocrinology; 2000 Dec; 141(12):4600-5. PubMed ID: 11108273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged remission of diabetes by regeneration of beta cells in diabetic mice treated with recombinant adenoviral vector expressing glucagon-like peptide-1.
    Liu MJ; Shin S; Li N; Shigihara T; Lee YS; Yoon JW; Jun HS
    Mol Ther; 2007 Jan; 15(1):86-93. PubMed ID: 17164779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon receptor antagonist-mediated improvements in glycemic control are dependent on functional pancreatic GLP-1 receptor.
    Gu W; Winters KA; Motani AS; Komorowski R; Zhang Y; Liu Q; Wu X; Rulifson IC; Sivits G; Graham M; Yan H; Wang P; Moore S; Meng T; Lindberg RA; Véniant MM
    Am J Physiol Endocrinol Metab; 2010 Oct; 299(4):E624-32. PubMed ID: 20647556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceleration of autoimmune diabetes in Rheb-congenic NOD mice with β-cell-specific mTORC1 activation.
    Sasaki H; Yasuda H; Moriyama H; Nakamura A; Shimizu M; Arai T; Nagata M; Hara K; Yokono K
    Biochem Biophys Res Commun; 2011 May; 408(2):306-11. PubMed ID: 21513702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased beta-cell proliferation and reduced mass before diabetes onset in the nonobese diabetic mouse.
    Sreenan S; Pick AJ; Levisetti M; Baldwin AC; Pugh W; Polonsky KS
    Diabetes; 1999 May; 48(5):989-96. PubMed ID: 10331402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of glucagon-like peptide-1 on beta- and alpha-cell function in isolated islet and whole pancreas transplant recipients.
    Rickels MR; Mueller R; Markmann JF; Naji A
    J Clin Endocrinol Metab; 2009 Jan; 94(1):181-9. PubMed ID: 18957498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taurine supplement in early life altered islet morphology, decreased insulitis and delayed the onset of diabetes in non-obese diabetic mice.
    Arany E; Strutt B; Romanus P; Remacle C; Reusens B; Hill DJ
    Diabetologia; 2004 Oct; 47(10):1831-7. PubMed ID: 15502919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PAHSAs attenuate immune responses and promote β cell survival in autoimmune diabetic mice.
    Syed I; Rubin de Celis MF; Mohan JF; Moraes-Vieira PM; Vijayakumar A; Nelson AT; Siegel D; Saghatelian A; Mathis D; Kahn BB
    J Clin Invest; 2019 Aug; 129(9):3717-3731. PubMed ID: 31380811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo expression of GLP-1/IgG-Fc fusion protein enhances beta-cell mass and protects against streptozotocin-induced diabetes.
    Soltani N; Kumar M; Glinka Y; Prud'homme GJ; Wang Q
    Gene Ther; 2007 Jun; 14(12):981-8. PubMed ID: 17410180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon-like peptide-1 can reverse the age-related decline in glucose tolerance in rats.
    Wang Y; Perfetti R; Greig NH; Holloway HW; DeOre KA; Montrose-Rafizadeh C; Elahi D; Egan JM
    J Clin Invest; 1997 Jun; 99(12):2883-9. PubMed ID: 9185511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total coumarins from Urtica dentata Hand prevent murine autoimmune diabetes via suppression of the TLR4-signaling pathways.
    Wang J; Lu J; Lan Y; Zhou H; Li W; Xiang M
    J Ethnopharmacol; 2013 Mar; 146(1):379-92. PubMed ID: 23340441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.